GBA's "2021 Stock Phantasma"

[stonedinvestor]

You could serve tea on that belly

 

[janes]

Most news around PLTR lately has been negative and I can't find any reason for the price spike up today. I also think some kind of positive news over the weekend or early next week.

about PLTR, they're saying it's because ARK bought a lot of stock last night and maybe today.

 

[stonedinvestor]

4:23 mark we aim to be the alcohol for Purell and all the other disinfectant brands for the west coast....

 

[stonedinvestor]

Yikes I see where this is all going-- It's Bladrunner... it's happening.

 

[stonedinvestor]

Who is Ark? Investment fund?

Van's Vietnam.

 

[stonedinvestor]

Wait I'm confused $27.50 or $25.50.??

I left the city I wrote down $27.50-PLTR What up? And now it's $25.50.

 

[stonedinvestor]

This name came up before memory memory..

How frustrating!

Collegium Pharmaceutical, Inc. (COLL)
24.08+1.79 (+8.03%)<--- why is this on my watch list???
As of 3:57PM EST. Market open.

 

[janes]

it dropped again (PLTR). I've been trading this one for a few weeks--buying at around 24 and selling at 26ish. i'm working on the assumption it won't really start going up until the earnings report and stock release. but who knows i guess.

 

[stonedinvestor]

--
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List 12/29 COLL, RVNC Needham analyst Serge Belanger named Collegium Pharmaceutical (COLL) as his 2021 best idea and added the company to Needham Conviction List in place of Revance Therapeutics (RVNC), which was removed. The analyst is also keeping his Buy rating and $34 price target on Collegium.

 

[stonedinvestor]

and then this Monday--

Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright 06:29 COLL H.C. Wainwright analyst Oren Livnat raised the firm's price target on Collegium Pharmaceutical to $33 from $29 and reiterates a Buy rating on the shares.